The mRNA Nobelist
In 1997, at a University of Pennsylvania photocopier, molecular biologist Katalin Karikó met immunologist Drew Weismann — a chance encounter that would change her career, and medicine, forever. At 42, Karikó had made little headway with her radical idea: that messenger RNA, the fleeting molecule that instructs cells to make proteins, could be harnessed to fight disease. Her grant proposals were repeatedly rejected. She had little funding, no staff, and scant recognition.
Weismann described his plans to create vaccines by delivering antigens into cells. Instantly, Karikó saw a new role for her pet molecule. Their collaboration would lay the foundation for the mRNA vaccines that proved vital during the COVID-19 pandemic.
In Breaking Through, Karikó recounts the origins and evolution of her scientific journey. She grew up in a small Hungarian town, the daughter of a butcher. A high school biology teacher introduced her to Hans Selye’s The Stress of Life — a book that shaped both her scientific outlook and her philosophy of living. “Do not blame. Focus on what you can control. Transform bad stress into good stress.” This mantra sustained her through decades of setbacks, when her work was belittled and her grants repeatedly denied.
Her greatest frustration came when synthetic mRNA triggered inflammation in cells. A vaccine might still be possible, she and Weismann reasoned, but therapeutic medicine would be impossible until they solved the immune activation problem. In 2005, they reported that modified mRNA avoided inflammation — a landmark finding later licensed by two biotech firms. Yet the discovery went largely unnoticed.
Stripped of funding, Karikó was relegated to a cramped lab, hardly fit for mRNA work. It was the last straw. In 2013, both BioNTech and Moderna — the firms that had licensed her breakthrough — offered her jobs. She left for Germany, while her husband and daughter Susan, now a two-time Olympic gold medalist, remained in the U.S. Karikó likens science to her daughter’s rowing: the crew rows backward, blind to the finish line, trusting that effort will carry them to the right destination.
Her discovery proved vital during the COVID-19 pandemic, but the story of synthetic mRNA is only beginning. Researchers are now exploring its potential for cancers, cystic fibrosis, rare metabolic disorders, and vaccines against other infectious diseases. Karikó predicts an explosion of mRNA therapies in the coming decade.
Breaking Through is both a testament to perseverance and a critique of a scientific reward system that nearly buried one of the century’s most transformative discoveries. It is a moving memoir that reminds us how much science depends not only on brilliance, but on resilience.
Epilogue
In 2023, Karikó and Weismann were awarded the Nobel Prize in Physiology or Medicine for their pioneering work on mRNA technology. The honor was a fitting culmination of a journey that began with rejection slips and cramped labs, and ended with a discovery that reshaped global health. Her memoir now reads not only as a chronicle of struggle and persistence, but as the backstory to a Nobel-worthy revolution in medicine.